Table of Contents
PISCATAWAY, N.J. — Camber Pharmaceuticals is pleased to announce the addition of paliperidone extended-release tablets to its current portfolio.Paliperidone extended- release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia, treatment of schizoaffective disorder as monotherapy, and as an adjunct to mood
stabilizers and/or antidepressants.
Paliperidone extended- release tablets are available in 1.5, 3, 6, and 9 mg strengths in 30 count bottles.
